Updates on the preoperative immunotherapy for triple-negative breast cancer.

Transl Breast Cancer Res · 2023 · PMC11092992 · PMID 38751476

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While the addition of durvalumab numerically increased pCR rates in all patients, this did not reach statistical significance ( 8 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.